Vivjoa Interactions
There are 42 drugs known to interact with Vivjoa (oteseconazole), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 2 are major, 38 are moderate, and 2 are minor.
- View all 42 medications that may interact with Vivjoa
- View Vivjoa alcohol/food interactions (1)
- View Vivjoa disease interactions (2)
Most frequently checked interactions
View interaction reports for Vivjoa (oteseconazole) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- albuterol
- alendronate
- ambrisentan
- Amondys 45 (casimersen)
- amoxicillin
- amoxicillin / clavulanate
- Anoro Ellipta (umeclidinium / vilanterol)
- apremilast
- aspirin
- atorvastatin
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Azithromycin Dose Pack (azithromycin)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- benzonatate
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blincyto (blinatumomab)
- boric acid topical
- cetirizine
- Cosentyx (secukinumab)
- guaifenesin
- Humira (adalimumab)
Vivjoa alcohol/food interactions
There is 1 alcohol/food interaction with Vivjoa (oteseconazole).
Vivjoa disease interactions
There are 2 disease interactions with Vivjoa (oteseconazole) which include:
Report options
QR code containing a link to this page
More about Vivjoa (oteseconazole)
- Vivjoa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: azole antifungals
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
